ZYDUSLIFEBSEZydus Lifesciences LtdHighPositive
Announced Tue, 19 May · 19:08 IST

Intimation about intention of promoters to participate in buyback

Buyback Premium Above 10pctCorporate Actions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹1017.70
prior close
₹1066.15
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.8+0.7+2.0+1.9+2.1+5.2+5.8+6.8+7.0+8.9+6.7+12.9
Up moveDown movePending
AI summary

Zydus Lifesciences has announced that its promoter group and persons in control have communicated their intention to participate in the company's upcoming buyback programme. The buyback involves up to 95,65,217 equity shares (0.95% of total paid-up capital) at INR 1,150 per share, aggregating to INR 1,100 crore. The buyback is being conducted on a proportionate basis through the tender offer route under the Companies Act, 2013 and SEBI Buyback Regulations. Promoters have indicated they will tender shares up to their respective holding or lower as permitted by law.

Likely market impact

Promoter participation signals confidence in the company's intrinsic value and may provide support to the stock. The INR 1,150 buyback price likely represents a premium to prevailing market rates, offering existing shareholders an opportunity to exit at a favourable price.